This invention relates to devices and methods for performing active, multi-step sample preparation and molecular diagnostic analysis of biological materials. More particularly, it relates to integrated, compact, portable devices for self-contained sample to answer systems. Specifically, this invention relates to a device and method for performing multi-step sample preparation and assay on either two or even a single microchip. Examples of applications for this integrated system include food and/or quality monitoring, diagnosis of infectious diseases and cancers, bone marrow plastesis (e.g., stem cell separation and analysis), and genetics-based identification of individuals for forensic purposes.
The following description provides a summary of information relevant to the present invention. It is not an admission that any of the information provided herein is prior art to the presently claimed invention, nor that any of the publications specifically or implicitly referenced are prior art to the invention.
Generally, analysis of biological-derived sample materials cannot occur until the sample is processed through numerous pre-analysis steps. Often, the preparation process is time consuming and laborious. For example, many immuno and molecular-biological diagnostic assays on clinical samples, such as blood or tissue cells, require separation of the molecules of interest from the crude sample by disrupting or lysing the cells to release such molecules including proteins and nucleic acids (i.e., DNA and RNA) of interest, followed by purification of such proteins and/or nucleic acids. Only after performing processing steps can analysis of the molecules of interest begin. Additionally, protocols used for the actual analysis of the samples require numerous more steps before useful data is obtained.
For example, charged and uncharged microparticles in solution (such as cellular material or crude extracts of protein or nucleic acids thereof) may be separated by dielectrophoresis. On a microscale, dielectrophoresis can be performed using a glass slide-based device having exposed, i.e., naked, interdigitated electrodes plated on the surface of the slide and having a flow chamber with a volume of several hundred microliters. With such a device, cells, proteins, and nucleic acids can be separated based on their respective dielectric properties by using separation buffers having appropriate conductivity and an AC signal with a suitable amplitude and frequency. Such devices, however, have several problems including the nonspecific binding of both separated and unseparated cells to exposed portions of the glass surface and the electrodes. Such devices are also problematic in that the flow chamber volume (several hundred microliters) is so large that thermal convection can disturb and push materials such as cells and large molecules initially attracted to and retained by the electrodes off of the electrodes. Additionally, undesired cells and molecules are not easily washed off the surface without disturbing and loosing the desired cells as such cells and molecules can interfere with fluidic flow and, hence, block the flow during wash steps.
Conventional methods to disrupt whole cells for the release of proteins and nucleic acids have employed the use of a series of high voltage DC pulses in a macrodevice, as opposed to a microchip-based device. Such conventional electronic lysis techniques have several problems. For example, some commercial macro-devices use lysis conditions that do not release high molecular weight (larger than 20 Kb) nucleic acids because the high molecular weight molecules can not fit through pores created in the cell membranes using such methods. Additionally, released nucleic acids are often lost due to their non-specific binding to the surface of the lysis chamber. Such loss of material, especially when molecules of interest are in low concentration, is further compounded by the fact that the dielectrophoretic cell separation macro-device systems are stand alone systems allowing for loss of sample in the transfer of material from one device to the other as sample preparation is carried forward.
Processing of the crude lysate often requires chemical reactions to remove undesired cellular components from the specifically desired ones. These reactions typically include subjecting the lysate to enzymatic reactions such as proteinase K and restriction enzymes or nucleases. Processing can also include enhancing the presence of desired molecules, particularly nucleic acids, by performing amplification reactions such as by strand displacement amplification (SDA) or polymerase chain reaction (PCR) methodologies. These reactions are also carried out in stand-alone processes. Only after these sample preparation and processing steps can assaying for data retrieval begin. Because of the numerous steps between sample collection and assay, many a technique is limited in its application by a lack of sensitivity, specificity, or reproducibility.
Attempts have been made to use dielectrophoresis to separate and identify whole cells. For example, U.S. Pat. No. 4,326,934 to Pohl discloses a method and apparatus for cell classification by continuous dielectrophoresis. With such method cells are separated by making use of both the positive and negative dielectrophoretic movement of cell particles. Separated cells are allowed to be characterized and/or classified by viewing the characteristic deflection distance of cells moving through the positive and negative electrodes.
In another example, U.S. Pat. No. 5,344,535 to Belts et al. discloses a method and apparatus for the characterization of micro-organisms and other particles by dielectrophoresis. In this system, cells are characterized by matching their signature dielectrophoretic collection rates.
In yet another example, U.S. Pat. No. 5,569,367 to Belts et al. discloses a method and apparatus for separating a mixture of cells using a pair of energized interdigitated electrodes comprised of interweaved grid-like structures arranged to obstruct flow of cells through the apparatus and cause differentiation of cell types into fractions by applying a non-uniform alternating field.
In addition, other attempts have been made to combine certain processing steps or substeps together. For example, various microrobotic systems have been proposed for preparing arrays of DNA probes on a support material. Beattie et al., disclose in “The 1992 San Diego Conference: Genetic Recognition”, November, 1992, use of a microrobotic system to deposit micro-droplets containing specific DNA sequences into individual microfabricated sample wells on a glass substrate.
Various other attempts have been made to describe integrated systems formed on a single chip or substrate, wherein multiple steps of an overall sample preparation and diagnostic system would be included. A. Manz et al., in “Miniaturized Total Chemical Analysis System: A Novel Concept For Chemical Sensing”, Sensors And Actuators, B1 (1990), pp. 244–248, describe a ‘total chemical analysis system’ (TAS) that comprises a modular construction of a miniaturized TAS. In that system, sample transport, chemical reactions, chromatographic separations and detection were to be automatically carried out.
Yet another proposed integrated system by Stapleton, U.S. Pat. No. 5,451,500, a system for automated detection of target nucleic acid sequences is described. In this system multiple biological samples are individually incorporated into matrices containing carriers in a two-dimensional format.
Various multiple electrode systems are also disclosed which purport to perform multiple aspects of biological sample preparation or analysis. Pace, U.S. Pat. No. 4,908,112, entitled “Silicon Semiconductor Wafer for Analyzing Micronic Biological Samples” describes an analytical separation device in which a capillary-sized conduit is formed by a channel in a semiconductor device, wherein electrodes are positioned in the channel to activate motion of liquids through the conduit. Additionally, Soane et al., in U.S. Pat. No. 5,126,022, entitled “Method and Device for Moving Molecules by the Application of a Plurality of Electrical Fields”, describes a system by which materials are moved through trenches by application of electric potentials to electrodes in which selected components may be guided to various trenches filled with antigen-antibodies reactive with given charged particles being moved in the medium or moved into contact with complementary components, dyes, fluorescent tags, radiolabels, enzyme-specific tags or other types of chemicals for any number of purposes such as various transformations which are either physical or chemical in nature. Further, Clark, et al. in U.S. Pat. No. 5,194,133, entitled “Sensor Devices”, discloses a sensor device for the analysis of a sample fluid which includes a substrate having a surface in which is formed an elongate micro-machined channel containing a material, such as starch, agarose, alginate, carrageenan or polyacrylamide polymer gel, for causing separation of the sample fluid as the fluid passes along the channel. The biological material may comprise, for example, a binding protein, an antibody, a lectin, an enzyme, a sequence of enzymes, or a lipid.
Various devices for eluting DNA from various surfaces are known. For example, Shukla U.S. Pat. No. 5,340,449, entitled “Apparatus for Electroelution” describes a system and method for the elution of macromolecules such as proteins and nucleic acids from solid phase matrix materials such as polyacrylamide, agarose and membranes such as PVDF in an electric field. Materials are eluted from the solid phase into a volume defined in part by molecular weight cut-off membranes. Also, Okano, et al. in U.S. Pat. No. 5,434,049, entitled “Separation of Polynucleotides Using Supports Having a Plurality of Electrode-Containing Cells” discloses a method for detecting a plurality of target polynucleotides in a sample, the method including the step of applying a potential to individual chambers so as to serve as electrodes to elute captured target polynucleotides, the eluted material is then available for collection.
Other devices for performing nucleic acid diagnosis have been designed wherein at least two reaction chambers are necessary for carryout the sample preparation and analysis such as R. Lipshutz, et al., entitled “Integrated Nucleic Acid Diagnostic Device” (U.S. Pat. No. 5,856,174) and R. Anderson, et al., entitled “Integrated Nucleic Acid Diagnostic Device”, (U.S. Pat. No. 5,922,591).
Still other achievements have been made toward partial integration of a complete sample handling system such as P. Wilding, et al., “Integrated cell isolation and PCR analysis using silicon microfilter-chambers,” Anal. Biochem. 257, pp. 95–100, 1998; and P. C. H. Li and D. J. Harrison, “Transport, manipulation, and reaction of biological cells on-chip using electrokinetic effects,” Anal. Chem., 69, pp. 1564–1568, 1997.
Still others have attempted to integrate chemical reactions with detection such as M. A. Burns, et al., “An integrated nanoliter DNA analysis device,” Science, 282, pp. 484–487, 1998; S. C. Jacobson and J. M. Ramsey, “Integrated microdevice for DNA restriction fragment analysis,” Anal. Chem., 68, pp. 720–723, 1996; L. C. Waters, et al., “Microchip device for cell lysis, multiplex PCR amplification, and electrophoretic sizing,” Anal. Chem., 70, pp. 158–162, 1998; and A. T. Woolley, et al., “Functional integration of PCR amplification and capillary electrophoresis in a microfabricated DNA analysis device,” Anal. Chem., 68, pp. 4081–4086, 1996.
Generally, as is understandable from the forgoing examples, systems and methods have been described that do not fully provide for a completely integrated self-contained sample to answer system that uses electronically active microchips. Moreover, numerous of the described systems are extremely labor and time intensive requiring multiple steps and human intervention either during the process or between processes which together are suboptimal allowing for loss of sample, contamination, and operator error. Further, the use of multiple processing steps using multiple machines or complicated robotic systems for performing the individual processes is often prohibitive except for the largest laboratories, both in terms of the expense and physical space requirements. For the reasons stated above, these techniques are limited and lacking. They are not easily combined to form a system that can carry out a complete self-contained integrated diagnostic assay, particularly assays for data retrieval for nucleic acids and protein-derived information, on a single electronically addressable microchip. Despite the long-recognized need for such an integrated system without a complicated fluidics and inadequate valve systems, no satisfactory solution has previously been proposed. There is therefore a continuing need for methods and devices which lead to improved dielectrophoretic separation of biological cells as well as improved biological stability of the separated cells and further a continuing need for methods and devices which improve cell preparation and analysis, and which are capable of integrating cell separation, preparation, purification, and analysis in a single self-contained system without complicated fluidics.
Accordingly, provided herein are integrated, portable systems, devices, and methods for performing active, integrated multi-step sample preparation and molecular diagnostic analysis of biological samples using electronically addressable microchips.
In one aspect of the present invention, an integrated system for the analysis of eukaroytic and/or prokaryotic cells in a biological sample is provided. The system comprises an electronic system for cell separation, cell lysis, sample preparation, and sample analysis further comprising a flow cell, an input port coupled to the flow cell, an output port coupled to the flow cell, a plurality of individually addressable electrodes positioned within the flow cell and coupled to a power source configured to electronically disrupt cell membranes within the sample, and an array of probes coupled to the electrodes and adapted to bind to predetermined components within the sample for analysis of the components, and a heating element coupled to the flow cell, wherein the flow cell is adapted to receive the sample via the input. The system further includes a detector operatively positioned to detect the molecules bound to the probes by a detectable signal, a power source coupled to the flow cell, and a portable housing configured to contain the electronic system, the detector, and the power source.
The system may include an illumination source operatively positioned to direct radiation to the probes. In one embodiment, the illumination source is a laser, and the system further comprises a beam splitter. This system may also comprise a desalting column coupled to the flow cell. The desalting column may be configured to introduce a buffer into the flow cell.
The electronic system may include a permeation layer overlaying the electrodes, and the probes may be coupled to the permeation layer. Additionally, in one embodiment, the electrodes are addressable to form a square-wall dielectric force pattern. Alternatively, in another embodiment, the electrodes are addressable to form a checkerboard dielectric force pattern. The system may also include a wave form generator coupled to the electrodes. The electronic system may also include first and second flow cells, wherein the first flow cell is configured for sample preparation, and the second flow cell is configured for sample analysis. Furthermore, a computer may be coupled to the portable housing and located outside of the portable housing.
In another aspect of the present invention, a method for performing an analysis of a biological sample having desired cells and undesired cells using an integrated portable system comprising a flow cell, a plurality of individually addressable electrodes positioned within the flow cell, and a portable housing containing the flow cell is provided. The sample may be introduced into the flow cell via an input port coupled to the flow cell. A dielectric force pattern may be created by individually biasing the electrodes positioned within the flow cell. The sample may then be subjected to the dielectric force pattern in order to separate the undesired cells from the desired cells in the sample. Then, the desired cells may be isolated by maintaining an attractive bias for the desired cells and introducing a flow of wash buffer through the flow cell via the input port to eliminate the undesired cells. Here, the undesired cells may be removed from the flow cell via an output port coupled to the flow cell. The desired cells may be lysed by applying an electric force within the flow cell to electronically disrupt the desired cells into a plurality of components. The components of the desired cells may then be analyzed by hybridizing the components with probes to form probe-target hybrids within the flow cell, and detecting the probe-target hybrids while the hybrids are within the flow cell, wherein the probes are coupled to the electrodes.
In one embodiment, the attractive bias maintained during the isolating the desired cells step comprises a square-wall dielectric force pattern. In another embodiment, the attractive bias maintained during the isolating the desired cells step comprises a checkerboard dielectric force pattern.
The isolation of the desired cells may be accomplished by generating a dielectric force pattern having a plurality of field maxima and a plurality of field minima, wherein the attractive bias comprises the field maxima, and the undesired cells collect at the field minima.
Creating a dielectric force pattern may be performed by biasing all of the individual electrodes as a single array. Alternatively, creating a dielectric force pattern may be performed by biasing the individual electrodes as a plurality of subarrays, wherein each subarray may be used for a function such as, e.g., cell separation, cell lysis, or cell analysis.
After lysing the desired cells, the desired cells may be purified by introducing a protease into the flow cell via the input port, maintaining a temperature of substantially 60° C. in the flow cell to treat the desired cells with the protease, and maintaining a temperature of substantially 95° C. in the flow cell to inactivate the protease after treating the desired cells with the protease. Maintaining a temperature may be accomplished using a heat element coupled to the flow cell and contained within the portable housing. Additionally, the purified desired cells may be treated with an enzyme to release a specific protein of interest from the desired cells. Here, the enzyme may be introduced into the flow cell via the input port. The specific protein of interest may then be amplified and labeled with a marker. Amplifying the specific protein of interest may be accomplished by suitable methods such as, e.g., PCR, or SDA.
The method may also include the detection of the probe-target hybrids by using fluorophore-labeled reporter probes and an optical imaging system configured to detect the reporter probes.
In another aspect of the present invention, a method for performing an analysis of a biological sample having desired cells and undesired cells using an integrated portable system is provided. An integrated portable system comprising an electronic system having a flow cell, a plurality of individually addressable electrodes positioned within the flow cell, a plurality of probes coupled to the electrodes, a detector configured to detect the probes, a power source coupled to the flow cell, and a portable housing containing the electronic system, the detector, and the power source may be provided. The sample may be introduced into the integrated portable system by injecting the sample into the flow cell via an input port coupled to the flow cell. The input port may be accessed through the portable housing. A dielectric force pattern may be created by individually biasing the electrodes positioned within the flow cell. The sample may be subject to the dielectric force pattern in order to separate the undesired cells from the desired cells in the sample. The desired cells may be isolated by maintaining an attractive bias for the desired cells and introducing a flow of wash buffer through the flow cell via the input port to eliminate the undesired cells. The undesired cells may be removed from the flow cell via an output port coupled to the flow cell. The desired cells may be lysed by applying an electric force within the flow cell to electronically disrupt the desired cells into a plurality of components. The components of the desired cells may then be analyzed by hybridizing the components with probes to form probe-target hybrids within the flow cell, and then detecting the probe-target hybrids while the hybrids are within the flow cell.
Regardless of the embodiment, the systems and methods of the invention generally provide the ability to (1) separate eukaryotic cell types from one another as well as eukaryotic cell types from prokarotic cell types, (2) directly process the sample materials from a crude state to a more refined state, and (3) directly analyze the sample materials on the microchip grid. Such an ability is possible by the novel use of electronic biasing at one level of voltage in the form of a dielectric current to cause dielectrophoresis of cells, followed by an increase in voltage to lyse captured cells, followed in turn by changing the manner of biasing from an alternating current mode to direct current mode for the addressing of specific electrodes on the arrays of the flow cell(s) to cause the transport of molecules of interest for capture/hybridization to probes previously bound to the electrode array. The present invention further contemplates that other appropriate sample preparation reagents may be transported to and away from the flow cell(s) by simplified arrangement of tubing and solenoid operated valves and pump. Additionally, in embodiments having a first flow chamber that is without a microchip, the system contemplates the ability to directly lyse the cells in the sample and analyze materials of interest without a need for separating the cell types. In such embodiment, the flow cell has a heating element that can be used to raise the temperature for direct lysis of the cells in the sample. Following such lysis, sample preparation steps such as protease treatment or nucleic acid amplification may be performed followed by transporting the amplified species to the second flow cell containing the electronically addressable microchip.
Also, numerous techniques can be performed in the preparation of molecules of interest including, but not limited to, enzymatic treatment using protease K to remove proteinaceous materials from nucleic acids of interest, enzymatic treatment using nucleases to remove nucleic acids from proteins, digestive residue adsorption, nucleic acid amplification (e.g., by PCR and SDA), in situ buffer exchange and binding of antibodies or other protein-protein binding reactions such as receptor-ligand or enzyme-substrate for binding to proteins of interest.
Analysis of prepared sample materials can also comprise any number of preselected hybridization formats. For example, nucleic acids of interest may be hybridized selectively through an electronically directed process as is known to those skilled in the art of electronically addressable microchips. Such hybridization formats comprise binding of nucleic acids (RNA, DNA, pNA) to probes anchored to the microarray. Other formats contemplated for use with the systems and methods of the present invention include selective capture of proteins of interest such as by antibody or other protein binding probes attached to the electronic grid. These can include other protein-protein interactions such as receptor-ligand and enzyme-substrate binding.
The present invention also contemplates the use of elements (e.g. buffer vials, tubing, miniature solenoid valves, and at least one pump) for carrying and transporting samples, buffers, enzymes and reagents to and from said flow cell(s). Additionally, other elements that may be used with the present invention include a battery operated diode laser (preferably having a wavelength of 635 nm), LEDs, and a CCD camera coupled with filters and zoom lens for astronomy of the individual electrodes of the microchip grid(s) of the first and/or second flow cell chamber(s). Still other methods of detection are also contemplated not requiring illumination with a light emitting device such as direct electrochemical detection as is well known by those in the art of such detection as described in P. Ropp and H. Holden Thorp, Chemistry & Biology, 1999, Vol. 6, No.9, pp. 599–605. Each of these electronic components are further contemplated to be coordinated through a computer and appropriate programming software as is well understood by those skilled in the electronic arts.
The invention will be further described with reference to the accompanying drawings in which:
Referring now to specific embodiments of the invention, a portable lab-on-a-chip system is provided wherein a sample may be processed and analyzed in at least a single flow cell comprising an electronically addressable microchip. The elements of the device are housed in a portable casing or housing which contains the sample preparation and analysis flow chamber, fluid handling systems, and illumination source (such as a battery operated 635 nm diode laser) and detection electronics (such as a CCD camera coupled with a set of filters and a zoom lens for astronomy of the microchip). External to the portable casing is a computer, such as a personal computer connected to the portable housing by a cable.
Referring now to
Sample handling in stage (1) processing generally comprises processing of crude biological samples (e.g., cells from blood, urine, stool, mixed cell populations, etc.) for the purpose of isolating molecules of interest such as nucleic acids and proteins. Sample handling at the chemical reaction stage (2) involves potentially many types of molecular biological reactions for clean-up and further isolation, purification, or amplification of molecules of interest including, but not limited to, enzymatic-based reactions such a treatment with proteases, nucleases and restriction enzyme digestion, PCR and SDA-based nucleic acid amplification, in situ buffer exchanges, chemical labeling such as by radioisotope and fluorescence markers, and immuno-based and protein-protein reactions such as antibody-antigen, ligand-receptor, and enzyme-substrate reactions. Sample handling at the analyte detection stage (3) may be accomplished through numerous formats including optical detection of fluorescent emissions, electrochemical detection, and radioisotope detection. In a preferred embodiment, this detection comprises hybridization of nucleic acids or captured proteins to the electronic grid and detection using fluorescent imaging.
In
As will be understood by one of skill in the art, the flow cell, as well as the other electrically operated components, such as solenoid operated valves and pumps, laser and detection camera, are interconnected electronically with the computer 20 by cabling 19 to the housing 18 for all programming and control purposes. By way of example, the power source and computer are connected to the electrodes of the flow cell 11 for programming and manipulation. In the preferred embodiment, the electronic signals that may be generated by the computer software used with the system include an AC component, such as where the AC component is sinusoidal and used in dielectrophoresis, and such as where a DC component is square and used in hybridization. In yet a further aspect, it is preferred that a time varying electronic signal also used in the system includes an offset signal, such as where the offset signal is a DC signal.
As an example of a flow cell design,
The microchip can be then attached to a molded or machined medical grade plastic flow cell 27 so that the electronic microarray 23 makes up the inner bottom surface of a well within the flow chamber. The flow cell 27 provides a compartment 29 for containing biological sample materials and buffers to be layered on top of the microchip. The flow cell may be further designed to have at least 2 to 4 ports 30 for sample delivery and extraction. The flow cell 27 may further be constructed so as to accept tubing for interfacing with exterior fluidic delivery and removal systems as well as desalting. Additionally, the flow cell compartment is covered and sealed by a fused quartz window or lid 28 for visual access to the microarray analysis sites or capture pads. This window 28 can comprise any thickness of quartz but generally is about 0.015 inches thick.
The window 28 may be attached to the flow cell and the flow cell to the chip by any number of methods of which a preferred method uses an ultraviolet (UV) curing adhesive 26 developed for optics assembly. Attachment of the flow cell to the chip may be either directly to a bare surface of the chip or to the permeation layer overlaying the microarray also using adhesive 26. Tubing is attached to the inlet and outlet ports using a variety of methods depending on the tubing size, fittings, and the tubing base material.
In an alternative embodiment, the integrated system may use two flow cells, one for sample preparation and the second for analysis.
The second flow cell 32 is used for sample analysis. In a preferred embodiment both flow cells 31 and 32 are disposed on the same side of the support 10. However, these flow cells may be disposed in alternative arrangements, including a back-to-back or a stacked configuration. Additionally, these two flow cells may be connected via a hollow fiber in order to purify, desalt and introduce different buffers into the flow stream. Moreover, each flow cell may be designed to have independent temperature control elements as desired. As will be understood by one of skill in the art, each of the electronically addressable microchips within the flow cells, as well as the other electrically operated components, such as solenoid operated valves and pumps, are interconnected electronically with the computer 20 by cabling for all programming and control purposes as in the single flow cell arrangement.
Whether using a single or multiple flow cell integrated system of the invention, cell separation is achieved by a dielectrophoresis technique. In such method, polarizeable particles (e.g., eukaryotic and prokaryotic cells) including those with no net charge are subject to a “dielectrophoretic” force of a non-uniform electrical field. As long as the effective polarizability of the particles is different from that of the surrounding medium, the cells will remain subject to the dielectric force. The direction of migration of different cell types is determined by: (1) surface charges of the cell walls or membranes of the cell bilipid membranes, (2) the conductivity and permitivity of such cell membranes and walls, and (3) the morphologies and structural architectures of the cells. Dielectrophoresis as practiced in the current invention has been used to selectively separate from mixed cell populations (e.g., blood cells) several types of bacteria including Escherichia coli, Salmonella typhimurium, Micrococcus lysodeikticus and Staphylococcus epidermidis as well as cancer cells such as cultured cervical carcinoma cells.
In a preferred embodiment, a flow cell useful for separating cells as practiced in this invention may be designed to include an electronically addressable microchip having at least 100 individually addressable microelectrodes capable of being biased individually so that a dielectric force pattern may be generated across the microchip electronic grid. For example,
Additionally, the electrodes of the microarray in the flow cell(s) may be biased either all together as a single array for carrying out cell separation, lysis, and analysis, or may be programmed to form subarrays in any number of patterns for carrying out the separation, lysis, and analysis steps. In other words, one subset may be biased to separate cells, another set may be biased to cause cell lysis, and yet another set may be used for analysis.
In an example of cell separation,
Undesired cells are washed from the flow chamber while retaining the cells of interest. This is accomplished by maintaining an attractive bias for the cells of interest and creating a flow of wash buffer through the flow chamber. Once the cells of interest are isolated in the flow chamber they may be treated in any number of ways for further processing. In one embodiment, the cells are lysed by applying high voltage pulses of up to 450 volts with a pulse width between 10 μs and 50 μs as described in J. Cheng, et al., “Preparation and hybridization analysis of DNA/RNA from E. coli on microfabricated bioelectronic chips,” Nature Biotechnol., 16, pp. 541–546, 1998. In another example, E. coli cells were separated from blood cells as shown in
In another example, mammalian cells are separated on the electronic grid of the flow chamber.
Following lysis, both cellular proteins and nucleic acids may be retained for analysis. An example showing that nucleic acid may be retained from lysed cells is provided in
Where nucleic acids are desired for analysis, further clean-up and purification may include treatment with proteases such as with Proteinase K. After such treatment, the lysate may either be analysed immediately, or amplified then analysed. If the alternate embodiment is used, the sample may be further treated in the flow chamber or may be exported to the second chamber for such protease treatment, amplification and analysis. Generally, a protease treatment may be carried out in an appropriate buffer at 60° C. for 15 min. Temperature control may be achieved by use of the ceramic heater element attached to the back of the microchip. Inactivation of proteinase K may be achieved by heating the sample at 95° C. for 2 min. Overall, the cell separation, lysis, and protease treatment process can take between 15–25 minutes.
Where proteins are desired, nucleic acids may be removed by treating the sample with restriction enzymes and nucleases. The proteins may further be treated with various enzymes and partial protease treatments to release specific proteins of interest from cell membranes and other cellular components. Following the above sample processing steps additional processing may be carried out including amplification (e.g., by PCR and SDA) and labeling with radioisotopic or fluorescent markers.
In an example of chemical reaction stage processing, specific nucleic acid sequences, (i.e., the invA and spa Q genes of Salmonella enterica) were amplified using SDA. SDA is preferred in this portable system as the amplification may be performed under isothermal conditions at between 50° C. and 60° C. thereby eliminating high temperature denaturation cycles associated with PCR. However, in one embodiment, the portable system is capable of performing PCR amplification as the flow chamber is equipped with the aforementioned heating element that has the capability of achieving repetitive high temperature cycling.
As shown in
The total nucleic acid from the bacteria cells was isolated by first lysing the cells by energizing the electrodes with pulsed direct current at 200 V having a square wave form af 10 ms duration and a total of 40 separate pulses. (Alternatively, the cells can be lysed by heating the chamber to 95° C. for five minutes). A concentrated SDA reagent and buffer stock mix was introduced into the flow cell and mixed with the denatured target nucleic acid to give the following final concentrations of SDA reaction components: 500 nM amplification primers, 50 nM ‘bumper’ primers, 9.5 mM magnesium acetate, 35 mM potassium phosphate buffer pH 7.6, 80 μg/ml bovine serum albumin, and 1.4 mM each of dATP, dGTP, TTP, and alpha-thiolated dCTP. The amplification primers were designed to amplify 81 base pairs of the invA or spa Q gene and comprised the following nucleic acid sequences:
spa Q Seq. Id. No. 1 5′-accgcatcgaatgcatgtctcgggtcctggtagggttattc-3′
spa Q Seq. Id. No. 2 5′-cgattccgctccagacttctcgggaacacacgccaagta-3′
inv A Seq. Id. No. 3 5′-accgcatcgaatgcatgtctcgggtttcaacgtttcctgcg-3′
inv A Seq. Id. No. 4 5′-cgattccgctccagacttctcgggatcgataatgccagacg-3′
Bumper primers comprised the following sequences:
spa Q Seq. Id. No. 5 5′-gcaacgattatcggc-3′
spa Q Seq. Id. No. 6 5′-ccagacagtaaaaac-3′
invA Seq. Id. No. 7 5′-ttgacagaatcctca-3′
inv A Seq. Id. No. 8 5′-taagacggctggta-3′
The released nucleic acid was then denatured by heating the chamber to 90° C. for five minutes. The chamber was then brought to 60° C. and 10 μl of SDA reagent buffer containing enzymes was introduced into the chamber to initiate amplification (i.e., 40 units of BsoB1 restriction endonuclease and 16 units of exo-Bst DNA polymerase).
In the system of the invention, amplification using SDA may be carried out for between 25 and 35 minutes. In the present example, after 30 minutes of reaction a 5 μl aliquot of the reaction volume was removed for PAGE analysis (
The third stage of sample handling comprising detection of the molecules of interest is preferably carried out for proteins and nucleic acids of interest. Such detection can use various forms of hybridization to probes previously attached to the microarray. For example, nucleic acids (e.g., RNA, DNA, and pNA) may be used for binding sample-derived nucleic acid analyte (e.g., amplified or unamplified target nucleic acids) by hybridization. Proteins may also be made to bind to capture molecules (i.e., protein-ligand binding interactions) attached to the array. Such capture molecules may comprise proteins or other molecules and the binding interaction can comprise such interactions as antigen-antibody, enzyme-substrate, and receptor-ligand binding.
With respect to nucleic acids, target species, whether amplified or not, are electronically addressed to specified capture pads of the microarray of either the single (or the secondary) flow chamber for capture by oligonucleotide probes that are anchored thereto. Preferably, the electrode array of the flow cell, (i.e., flow cell 11, 31a or 32 depending upon the embodiment and protocol used) has at least 25 individually-addressable electrodes coated with a permeation layer (e.g. for example, an acrylamide-based hydro-gel). The target nucleic acid is biased using a positive sinusoidal signal generated using a function generator/arbitrary wave form generator (33120A, Hewlett Packard, Santa Clara, Calif.). The capture probe-target hybrids are then detected using fluorophore-labeled reporter probes and the CCD-based optical imaging system employed for the portable instrument shown in
Continuing with the above example, the amplification products of the spa Q and inv A genes were available for capture and analysis. Prior to capture, the SDA reaction solution and amplification products were passed through a desalting column in a volume of about 75 ul followed by exchanging the buffer with a 50 mM Histidine buffer. The amplification products were then addressed to specific pads of the electrodes which contained gene specific probes attached to the permeation layer overlaying the electrodes. This was followed by washing the chamber with 200 mM NaCl, 10 mM Tris pH 8.0, 1 mMEDTA, followed in turn by introduction of a bodipy 630-labeled probe oligonucleotide specific for the amplification product at a concentration of 0.5 μM in 200 mM NaCl, 10 mM Tris pH 8.0, 1 mM EDTA, and 100 ug/ml Calf Thymus DNA. The reporter probe solution was left in the assay cell for 10 minutes then washed with 7–800 μl of 50 mM Histidine buffer. The chamber was then visualized using a 630 nM helium-neon laser and a computer controlled CCD camera.
In
Visual detection of amplification reaction products by probe hybridization may be performed by directing a battery operated diode laser having at least the capability of generating approximately 2 mWatts of laser power with an emission wavelength of 635 nm. The laser is used to excite fluorescent dye-label reporter probe (such as BODIPY-630). The wavelength of the emission filter is 670 nm. The dichromatic mirror has a wavelength cutoff at 645 nm. Alternatively, a direct electrochemical voltammetric detection system may also be used instead of light based detection as is understood by those skilled in the art.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity and understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.
This application is a continuation of application Ser. No. 09/470,448, filed Dec. 22, 1999 now U.S. Pat. No. 6,403,367, entitled “Integrated Portable Biological Detection System”, which claims benefit of Provisional Patent Application Ser. No. 60/113,730, filed Dec. 23, 1998, entitled “Fluorescent Imaging of Cells and Nucleic Acids in Bioelectronic Chips”, and is a continuation-in-part of application Ser. No. 09/016,596, filed on Jan. 30, 1998, entitled “Channel-Less Separation of Bioparticles on a Bioelectronic Chip by Dielectrophoresis”, now issued as U.S. Pat. No. 6,071,394, which is a continuation in part of application Ser. No. 08/709,358, filed on Sep. 6, 1996, entitled “Apparatus and Methods for Active Biological Sample Preparation”, now issued as U.S. Pat. No. 6,129,828, and is a continuation-in-part of application Ser. No. 08/986,065, filed on Dec. 5, 1997, entitled “Methods and Procedures for Molecular Biological Analysis and Diagnostics”, now issued as U.S. Pat. No. 6,051,380, which is a continuation-in-part of application Ser. No. 08/534,454, filed Sep. 27, 1995, entitled “Methods for Hybridization Analysis Utilizing Electrically Controlled Hybridization”, now issued as U.S. Pat. No. 5,849,486, which is a continuation-in-part of application Ser. No. 08/304,657, filed Sep. 9, 1994, entitled “Molecular Biological Diagnostic Systems Including Electrodes”, now issued as U.S. Pat. No. 5,632,957, which is a continuation-in-part of application Ser. No. 08/271,882, filed Jul. 7, 1994, entitled “Methods for Electronic Stringency Control for Molecular Biological Analysis and Diagnostics”, now issued as U.S. Pat. No. 6,017,696, the specifications of which are hereby expressly and fully incorporated by reference as if fully set forth herein.
The Government has rights in this invention pursuant to Grant No. ATP: 70NANB7H3001 awarded by the Advanced Technology Program.
Number | Name | Date | Kind |
---|---|---|---|
3346479 | Natelson | Oct 1967 | A |
3375187 | Buchler | Mar 1968 | A |
3533933 | Strauch | Oct 1970 | A |
3539493 | Dorman | Nov 1970 | A |
3616454 | Levy et al. | Oct 1971 | A |
3627137 | Bier | Dec 1971 | A |
3640813 | Nerenberg | Feb 1972 | A |
3697405 | Butter et al. | Oct 1972 | A |
3773648 | Van Welzen et al. | Nov 1973 | A |
3791950 | Allington | Feb 1974 | A |
3902986 | Nees | Sep 1975 | A |
3950738 | Hayashi et al. | Apr 1976 | A |
3980546 | Cavacco | Sep 1976 | A |
3995190 | Salgo | Nov 1976 | A |
4283773 | Daughton et al. | Aug 1981 | A |
4326934 | Pohl | Apr 1982 | A |
4479861 | Hedinger | Oct 1984 | A |
4555731 | Zinchuk | Nov 1985 | A |
4563419 | Ranki et al. | Jan 1986 | A |
4572668 | Auth | Feb 1986 | A |
4580895 | Patel | Apr 1986 | A |
4584075 | Goldstein | Apr 1986 | A |
4594135 | Goldstein | Jun 1986 | A |
4617102 | Tomblin et al. | Oct 1986 | A |
4699706 | Burd et al. | Oct 1987 | A |
4707235 | Englert et al. | Nov 1987 | A |
4737259 | Ogawa et al. | Apr 1988 | A |
4751177 | Stabinsky | Jun 1988 | A |
4787963 | MacConnell | Nov 1988 | A |
4807161 | Comfort et al. | Feb 1989 | A |
4816418 | Mack et al. | Mar 1989 | A |
4822566 | Newman | Apr 1989 | A |
4827125 | Goldstein | May 1989 | A |
4828729 | Klevan et al. | May 1989 | A |
4877510 | Chen | Oct 1989 | A |
4881107 | Matsushita | Nov 1989 | A |
4881812 | Ohkubo et al. | Nov 1989 | A |
4908112 | Pace | Mar 1990 | A |
4936963 | Mandecki et al. | Jun 1990 | A |
5063081 | Cozzette et al. | Nov 1991 | A |
5074977 | Cheung et al. | Dec 1991 | A |
5075077 | Durley, III et al. | Dec 1991 | A |
5082548 | Faupel et al. | Jan 1992 | A |
5085756 | Swedberg | Feb 1992 | A |
5096669 | Lauks et al. | Mar 1992 | A |
5096807 | Leaback | Mar 1992 | A |
5125748 | Bjornson et al. | Jun 1992 | A |
5126022 | Soane et al. | Jun 1992 | A |
5143854 | Pirrung et al. | Sep 1992 | A |
5161165 | Zorabedian | Nov 1992 | A |
5164319 | Hafeman et al. | Nov 1992 | A |
5166063 | Johnson | Nov 1992 | A |
5192980 | Dixon et al. | Mar 1993 | A |
5194133 | Clark et al. | Mar 1993 | A |
5200051 | Cozzette et al. | Apr 1993 | A |
5202010 | Guzman | Apr 1993 | A |
5202231 | Drmanac et al. | Apr 1993 | A |
5209831 | MacConnell | May 1993 | A |
5217593 | MacConnell | Jun 1993 | A |
5219726 | Evans | Jun 1993 | A |
5227265 | DeBoer et al. | Jul 1993 | A |
5229297 | Schnilpelsky et al. | Jul 1993 | A |
5234566 | Osman et al. | Aug 1993 | A |
5242797 | Hirschfeld | Sep 1993 | A |
5269931 | Hu et al. | Dec 1993 | A |
5296114 | Manz | Mar 1994 | A |
5296703 | Tsien | Mar 1994 | A |
5304487 | Wilding et al. | Apr 1994 | A |
5312527 | Mikkelsen et al. | May 1994 | A |
5316900 | Tsujioka et al. | May 1994 | A |
5324401 | Yeung et al. | Jun 1994 | A |
5340449 | Chukla | Aug 1994 | A |
5344535 | Betts et al. | Sep 1994 | A |
5376249 | Afeyan | Dec 1994 | A |
5382511 | Stapleton | Jan 1995 | A |
5393401 | Knoll | Feb 1995 | A |
5427664 | Stoev et al. | Jun 1995 | A |
5427946 | Kricka et al. | Jun 1995 | A |
5433819 | McMeen | Jul 1995 | A |
5434049 | Okano et al. | Jul 1995 | A |
5436129 | Stapleton | Jul 1995 | A |
5445525 | Broadbent et al. | Aug 1995 | A |
5445934 | Fodor et al. | Aug 1995 | A |
5451500 | Stapleton | Sep 1995 | A |
5464517 | Hjerten et al. | Nov 1995 | A |
5468646 | Mattingly | Nov 1995 | A |
5486335 | Wilding et al. | Jan 1996 | A |
5489506 | Crane | Feb 1996 | A |
5498392 | Wilding et al. | Mar 1996 | A |
5516698 | Begg et al. | May 1996 | A |
5527670 | Stanley | Jun 1996 | A |
5545531 | Rava et al. | Aug 1996 | A |
5567617 | Caprio et al. | Oct 1996 | A |
5569367 | Betts et al. | Oct 1996 | A |
5587128 | Wilding et al. | Dec 1996 | A |
5593580 | Kopf | Jan 1997 | A |
5593838 | Zansucchi et al. | Jan 1997 | A |
5605662 | Heller et al. | Feb 1997 | A |
5631734 | Stern et al. | May 1997 | A |
5632876 | Zanzucchi et al. | May 1997 | A |
5632957 | Heller et al. | May 1997 | A |
5635358 | Wilding et al. | Jun 1997 | A |
5637469 | Wilding et al. | Jun 1997 | A |
5653939 | Hollis et al. | Aug 1997 | A |
5660701 | Grushka et al. | Aug 1997 | A |
5667667 | Southern | Sep 1997 | A |
5681751 | Begg et al. | Oct 1997 | A |
5700637 | Southern | Dec 1997 | A |
5726026 | Wilding et al. | Mar 1998 | A |
5728267 | Flaherty | Mar 1998 | A |
5744366 | Kricka et al. | Apr 1998 | A |
5746978 | Bienhaus et al. | May 1998 | A |
5750015 | Soane et al. | May 1998 | A |
5755942 | Zanzucchi et al. | May 1998 | A |
5766960 | Cornell et al. | Jun 1998 | A |
5788468 | Dewa et al. | Aug 1998 | A |
5789167 | Konrad | Aug 1998 | A |
5824204 | Jerman | Oct 1998 | A |
5849486 | Heller et al. | Dec 1998 | A |
5856174 | Lipshutz | Jan 1999 | A |
5858195 | Ramsey | Jan 1999 | A |
5858804 | Zanzucchi et al. | Jan 1999 | A |
5863502 | Southgate et al. | Jan 1999 | A |
5863708 | Zanzucchi et al. | Jan 1999 | A |
5879632 | Demers | Mar 1999 | A |
5882903 | Andrevski et al. | Mar 1999 | A |
5891630 | Eggers et al. | Apr 1999 | A |
5922591 | Anderson | Jul 1999 | A |
5939291 | Loewy et al. | Aug 1999 | A |
5958344 | Levine et al. | Sep 1999 | A |
6007690 | Nelson et al. | Dec 1999 | A |
6013166 | Heller | Jan 2000 | A |
6017696 | Heller et al. | Jan 2000 | A |
6048690 | Heller et al. | Apr 2000 | A |
6051380 | Sosnowski et al. | Apr 2000 | A |
6054270 | Southern | Apr 2000 | A |
6071394 | Cheng et al. | Jun 2000 | A |
6258606 | Kovacs | Jul 2001 | B1 |
6264815 | Pethig et al. | Jul 2001 | B1 |
6280590 | Cheng et al. | Aug 2001 | B1 |
6326211 | Anderson et al. | Dec 2001 | B1 |
6395489 | Stanley | May 2002 | B1 |
6403367 | Cheng et al. | Jun 2002 | B1 |
Number | Date | Country |
---|---|---|
0228075 | Jul 1987 | EP |
2156074 | Oct 1985 | GB |
2247889 | Mar 1992 | GB |
WO8603782 | Jul 1986 | WO |
WO8808528 | Nov 1988 | WO |
WO8901159 | Feb 1989 | WO |
WO8910977 | Nov 1989 | WO |
WO9001564 | Feb 1990 | WO |
WO9204470 | Mar 1992 | WO |
WO9322678 | Nov 1993 | WO |
WO9507363 | Mar 1995 | WO |
WO9601836 | Jan 1996 | WO |
WO9801758 | Jan 1998 | WO |
WO9851819 | Nov 1998 | WO |
57087 | Aug 1912 | YU |
Number | Date | Country | |
---|---|---|---|
20020155586 A1 | Oct 2002 | US |
Number | Date | Country | |
---|---|---|---|
60113730 | Dec 1998 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09470448 | Dec 1999 | US |
Child | 10163835 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09016596 | Jan 1998 | US |
Child | 09470448 | US | |
Parent | 08986065 | Dec 1997 | US |
Child | 09016596 | US | |
Parent | 08709358 | Sep 1996 | US |
Child | 08986065 | US | |
Parent | 08534454 | Sep 1995 | US |
Child | 08709358 | US | |
Parent | 08304657 | Sep 1994 | US |
Child | 08534454 | US | |
Parent | 08271882 | Jul 1994 | US |
Child | 08304657 | US |